Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Aklief (Trifarotene-topical).
Exposure to sunlight: Aklief (Trifarotene-topical) can make the skin more sensitive to sunlight. Make sure you use sunscreen (minimum SPF 30) and protective clothing when exposed to sunlight. If you have a Sunburn, you should not use trifarotene until you have fully recovered.
Skin Care: Trifarotene can make your skin dry and possibly irritated. It is important to avoid using other skin products or treatments with strong drying or irritant effects. These products and procedures may include electrolysis, hair depilatories, medicated soaps or shampoos, permanent wave solution, waxes, and products containing high amounts of alcohol, astringents, spices, or lime peel.
Exposure to wind and cold may also dry and irritate your skin.
Other acne medications may contribute to skin irritation. Discuss your options with your doctor.
Pregnancy: It is recommended that pregnant women do not use trifarotene. When similar medications have been taken by mouth during pregnancy, the babies born to these women were at an increased risk of birth defects. Because the amount of Aklief (Trifarotene-topical) that is absorbed through the skin varies, there is a risk that the unborn baby may be exposed to trifarotene if it is used during pregnancy. Women who may become pregnant should use an effective method of birth control while using Aklief (Trifarotene-topical). If you become pregnant while taking Aklief (Trifarotene-topical), contact your doctor immediately.
Breast-feeding: It is not known if trifarotene passes into breast milk. If you are a breast-feeding mother and are taking this medication, it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of this medication have not been established for children less than 12 years of age.